Related Experiment Video
Updated: Jun 18, 2026
05:04
Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
Published on: August 9, 2024
Statin initiation by GPs in WA--a structured vignette study.
Leanne Stafford1, Nichola Harmer, Satvinder Dhaliwal
1Curtin Health Innovation Research Institute, School of Pharmacy, Curtin University of Technology, Perth, Western Australia. l.stafford@curtin.edu.au
Australian Family Physician
|November 7, 2009
Summary
Statin prescribing for coronary heart disease patients in Western Australia fell short of guidelines in over 20% of cases. Factors like prescriber experience and patient conditions influenced statin initiation.
Area of Science:
- Cardiology
- General Practice
- Pharmacotherapy
Background:
- Coronary heart disease (CHD) management guidelines recommend statin therapy for all affected patients.
- This pilot study examined statin initiation practices among Western Australian general practitioners (GPs).
- The research explored how prescriber and patient characteristics impact statin prescribing decisions.
Purpose of the Study:
- To assess the adherence of general practitioners to current guidelines for statin initiation in patients with coronary heart disease.
- To identify factors related to general practitioners and patients that influence the decision to prescribe statins post-myocardial infarction.
Main Methods:
- A structured vignette questionnaire was distributed to general practitioners in the Fremantle GP Network.
- Respondents indicated their prescribing choices for nine hypothetical post-myocardial infarction patient scenarios.
- Logistic regression and a generalized linear model with a logit link function were employed for data analysis.
Main Results:
- A response rate of 16.0% was achieved, with 55 GPs participating.
- Statins were not prescribed in over 20% of the presented cases.
- Prescriber characteristics (male gender, fewer years in practice) and patient factors (younger age, diabetes, hypercholesterolemia) were associated with statin prescribing likelihood.
Conclusions:
- A significant proportion of general practitioners did not adhere to established guidelines for statin prescribing in post-myocardial infarction patients.
- These findings highlight potential gaps in guideline implementation for cardiovascular pharmacotherapy.
- Further research is recommended to validate these observations and explore underlying reasons for non-compliance.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:18Guidelines and Strategies for Safe Computer Charting
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Maintain Confidentiality and Security:
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...